[
  {
    "ts": null,
    "headline": "Is Inari Medical Inc. (NARI) Firm Posts Strong Gain Amid Wall Street Bloodbath?",
    "summary": "We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed sharply in the red on Tuesday, as investors […]",
    "url": "https://finnhub.io/api/news?id=ae57e2e3eb359f17c5d3f0fa9268da5c1bc708de76d0a77a0d9196e350c6e4d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736367431,
      "headline": "Is Inari Medical Inc. (NARI) Firm Posts Strong Gain Amid Wall Street Bloodbath?",
      "id": 132329869,
      "image": "https://s.yimg.com/ny/api/res/1.2/ofzw0klaSexnJhNyX2R3ig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/b1a7101a606d3d35c4b70a0402637ff3",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other firms post strong gains amid Wall Street bloodbath. Wall Street’s main indices closed sharply in the red on Tuesday, as investors […]",
      "url": "https://finnhub.io/api/news?id=ae57e2e3eb359f17c5d3f0fa9268da5c1bc708de76d0a77a0d9196e350c6e4d8"
    }
  },
  {
    "ts": null,
    "headline": "'Physical AI': An All-Robotics Portfolio Sleeve, Preparing For 'Thor'",
    "summary": "Nvidia's CEO highlights robotics advancements at CES. Learn why our rankings of top robotics and AI stocks include both blue chips and small-cap growth stories.",
    "url": "https://finnhub.io/api/news?id=76a66ea49fb7e890f528dd170be60b91aa2925c689235be69603fb444279a2a7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736354754,
      "headline": "'Physical AI': An All-Robotics Portfolio Sleeve, Preparing For 'Thor'",
      "id": 132331414,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1555754760/image_1555754760.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "Nvidia's CEO highlights robotics advancements at CES. Learn why our rankings of top robotics and AI stocks include both blue chips and small-cap growth stories.",
      "url": "https://finnhub.io/api/news?id=76a66ea49fb7e890f528dd170be60b91aa2925c689235be69603fb444279a2a7"
    }
  },
  {
    "ts": null,
    "headline": "PAHC or SYK: Which Is the Better Value Stock Right Now?",
    "summary": "PAHC vs. SYK: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=ec2e738c29d2b4848c1bfb44ae77bcf1052de722942af8e3fdabbb3728dd639a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736354413,
      "headline": "PAHC or SYK: Which Is the Better Value Stock Right Now?",
      "id": 132320279,
      "image": "https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "PAHC vs. SYK: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=ec2e738c29d2b4848c1bfb44ae77bcf1052de722942af8e3fdabbb3728dd639a"
    }
  },
  {
    "ts": null,
    "headline": "Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset",
    "summary": "Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Learn more on SYK stock here.",
    "url": "https://finnhub.io/api/news?id=87d0d384d748ad6d1bf599c10bc381505dc40cf6f51ed49e2b62d2fe67b84efb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736344771,
      "headline": "Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset",
      "id": 132320000,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1297034305/image_1297034305.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Learn more on SYK stock here.",
      "url": "https://finnhub.io/api/news?id=87d0d384d748ad6d1bf599c10bc381505dc40cf6f51ed49e2b62d2fe67b84efb"
    }
  },
  {
    "ts": null,
    "headline": "Stryker’s Strategic Acquisition of Inari Medical Announced",
    "summary": "Stryker ( (SYK) ) has provided an announcement. Stryker Corporation has announced a definitive agreement to acquire Inari Medical, Inc. for $80 per share, with a total equity value of approximately $4.9 billion. This acquisition is set to enhance Stryker’s position in the peripheral vascular segment, expanding its portfolio with Inari’s innovative solutions for venous thromboembolism, complementing Stryker’s existing Neurovascular business. The transaction, expected to close by the first quarter",
    "url": "https://finnhub.io/api/news?id=f08c1681ec4cd1015a1b1edb7ae32ee23f3145dca10aef99db9eeb8bcb80eca7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736338693,
      "headline": "Stryker’s Strategic Acquisition of Inari Medical Announced",
      "id": 132317103,
      "image": "",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker ( (SYK) ) has provided an announcement. Stryker Corporation has announced a definitive agreement to acquire Inari Medical, Inc. for $80 per share, with a total equity value of approximately $4.9 billion. This acquisition is set to enhance Stryker’s position in the peripheral vascular segment, expanding its portfolio with Inari’s innovative solutions for venous thromboembolism, complementing Stryker’s existing Neurovascular business. The transaction, expected to close by the first quarter",
      "url": "https://finnhub.io/api/news?id=f08c1681ec4cd1015a1b1edb7ae32ee23f3145dca10aef99db9eeb8bcb80eca7"
    }
  },
  {
    "ts": null,
    "headline": "Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical",
    "summary": "Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for investors. Learn more on SYK stock here.",
    "url": "https://finnhub.io/api/news?id=2b5cd55658be58f7ea500148a3a5e293bb6ea29c1ee67cf5b0e782bf208a0a78",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736336999,
      "headline": "Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical",
      "id": 132317735,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2153990274/image_2153990274.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for investors. Learn more on SYK stock here.",
      "url": "https://finnhub.io/api/news?id=2b5cd55658be58f7ea500148a3a5e293bb6ea29c1ee67cf5b0e782bf208a0a78"
    }
  }
]